ANJAC SAS

What ANJAC SAS does

ANJAC SAS is a French family-owned industrial group operating as a Contract Development and Manufacturing Organization (CDMO) for the beauty, health, and nutraceutical sectors. The group comprises 16 specialized subsidiary companies and 22 production and R&D sites across France, the United States (California), Canada, Spain, and Slovenia, employing roughly 3,100-3,200 people and serving more than 600 active customers worldwide, from international cosmetics and pharmaceutical multinationals to independent indie brands.

The platform provides full value-chain coverage spanning concept creation, custom ingredients, formulation, packaging sourcing, industrialization, filling, kitting, and regulatory support. Core proprietary technologies include the patent-pending Biodis+ nanoemulsion platform (High Pressure Homogenization for enhanced active penetration and SPF performance), Cicalyte electrolyte bioactive solutions for ENT and mucosal applications, Emulpro microdroplet emulsions preserving the cutaneous microbiome, and Süvy, a 1:1 sugar alternative developed over seven years at Laboratoires Innovi. Manufacturing capacity is approximately 60 million units per month, supported by 150+ researchers across 15 R&D laboratories, 10 cross-innovation labs, and 5% of revenue reinvested annually into R&D, yielding roughly 200 innovations and 20 bestsellers per year. Regulatory credentials include FDA, cGMP, ISO 13485, MDR, and COSMOS certifications across multiple subsidiaries.

ANJAC generates revenue through professional service fees, project-based formulation engagements, and recurring manufacturing contracts with beauty, pharmaceutical, and nutraceutical brands. Revenue is diversified across three segments: beauty and cosmetics (cosmetics leaders and indie brands), health-pharma (approximately 30% of group revenue, including Laboratoires Chemineau, Feltor, Pillar5 Pharma, and Cosmetix West), and nutraceuticals (PharmaLinea, LPEV, Innovi, and the newly acquired HCG). The go-to-market is enterprise field sales, reinforced by participation in Cosmoprof, CPHI, MakeUp in Los Angeles, Paris Packaging Week, and Cosmetic 360, alongside the recently opened Maison ANJAC B2B experiential hub in Paris. Recent strategic activity has been acquisition-led, with the HCG (2025) and APR Beauty (2024) deals extending the group into Slovenia and North America and contributing roughly €70M of incremental annualized revenue on top of the €800M 2024 base.

Name

ANJAC SAS

Legal name

ANJAC SAS

Website

https://anjac.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

ANJAC SAS is a French family-owned CDMO operating 16 specialized companies and 22 production sites across five countries, providing formulation, manufacturing, and packaging services to 600+ beauty, pharmaceutical, and nutraceutical brand customers with proprietary platforms including Biodis+ nanoemulsions and Emulpro.

Ownership category

akta.pro rank

Product category

Contract Manufacturing and Development Services (CDMO)

NAICS

Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industries

Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ)

Keywords

• Contract manufacturing services
• Beauty formulation development
• Nutraceutical manufacturing
• Cosmetic packaging services
• Pharmaceutical CDMO

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices26 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. CDMO Manufacturing & Formulation Services: ANJAC generates revenue as a contract development and manufacturing organization (CDMO), providing formulation, manufacturing, and packaging services to beauty, health, and nutraceutical brands. Revenue is derived from service fees and product manufacturing across 16 subsidiary companies serving over 600 active customers worldwide. The group operates on a project-based and recurring manufacturing model with both one-time product development fees and ongoing production contracts.
2. Health-Pharma Products: The health-pharma business unit generates approximately 30% of group revenue through the manufacture of topical/oral pharmaceuticals, medical devices, OTC products, and drug formulations across subsidiaries including Chemineau, Feltor, Cosmetix West, Pillar5 Pharma, Eurowipes, Shadeline, Innovi, and Roval.
3. Nutraceutical Products: Revenue from dietary supplements and nutraceutical products, strengthened by the HCG acquisition adding approximately €30 million in additional revenue. Covers formats including capsules, tablets, liquids, powders, softgels, gummies, and chocolate.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels10 records

Core offering

ANJAC SAS is a French family-owned Contract Development and Manufacturing Organization (CDMO) operating through 16 subsidiary companies and 22 production sites. It provides turnkey formulation, manufacturing, and packaging services for beauty (makeup, skincare, fragrance, personal care), health-pharma (topical/oral drugs, medical devices, OTC products), and nutraceutical (dietary supplements, food supplements) products. The group serves over 600 brands worldwide with ~60 million units produced monthly and fast-track launches from 4 months.

Product overview

ANJAC Health & Beauty is a French industrial CDMO (Contract Development and Manufacturing Organization) group comprising 16 expert subsidiaries that operate as a unified platform for formulation, manufacturing, and packaging of health, beauty, and nutraceutical products. The portfolio includes makeup specialists (Aircos Pascual, APR Beauty), personal care manufacturers (Apollo, Cosmetix West), health/pharma companies (Chemineau, Feltor), clean beauty brands (Eurowipes), and nutraceutical specialists (PharmaLinea, LPEV, Innovi). Core platform capabilities are supported by specialized technologies including BIODIS+ nanoemulsion platform, Cicalyte bioactive electrolytes, and Emulpro emulsions. The group operates 22 production sites across France, Spain, USA, and Canada, serving 600+ clients from startups to multinationals with rapid launch capabilities from 4 months. A €25M investment in HCG's Slovenia facility will triple production capacity by end of 2026.

Differentiator

Problem solved

Functional benefit

Brands

• Maison ANJAC: Experiential B2B space and headquarters located in Paris, serving as innovation hub and client collaboration center
• Süvy
• Biodis+ Technology
• Cicalyte
• Emulpro

Products and services

• CDMO Manufacturing & Formulation Services Turnkey contract development and manufacturing services covering concept creation, custom ingredients, formulation, packaging sourcing, industrialization, filling, kitting, and regulatory support (PIFs, MDR, FDA) for beauty, health-pharma, and nutraceutical brands.
• Pharmaceutical & Health Manufacturing Services Development and manufacturing of topical and oral pharmaceutical formulations, medical devices, OTC products, preservative-free systems, nasal sprays, dermatology solutions, and women's health products for pharmaceutical and healthcare clients.
• Beauty & Cosmetics Manufacturing Services Turnkey cosmetic formulation, manufacturing, and packaging services for color cosmetics, personal care, skin health, UV protection, hair care, dermocosmetics, and fragrance products serving international cosmetics leaders and independent brands.
• Nutraceutical Manufacturing Services

Quantifiable outcome

• 300% revenue growth in 5 years (approaching €800M)
• +7 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Ceres Brain TherapeuticscoreStrategic or Co-development Partner · 27 January 2025ANJAC led a €6+ million funding round for Ceres Brain Therapeutics, a biotech spin-off from the CEA developing CBT101, a nasal spray medication targeting creatine transporter deficiency and ALS. ANJAC's support includes pharmaceutical development expertise (CMC), manufacturing capabilities through Laboratoires Chemineau, and nearly €3M in Bpifrance funding secured through the #France2030 program. Phase 1 clinical trials on healthy volunteers planned for 2025, Phase 2 proof-of-concept in 2026/2027.
• Le French GutminorStrategic or Co-development Partner · 9 January 2025ANJAC joined the Le French Gut scientific project led by INRAE in partnership with AP-HP and other stakeholders, aiming to map the gut microbiota of 100,000 volunteers by 2029. The project is part of the global Million Microbiome of Humans Project (MMHP). ANJAC contributes to advance knowledge in health innovation, with Innovi laboratories driving internal innovation projects from this research. Employees are encouraged to participate as volunteers.
• FairglowcoreTechnology or Integration · 1 January 2024ANJAC became the first CDMO to integrate Fairglow's AI-powered Life Cycle Assessment (LCA) platform, dedicated to the cosmetics industry. Fairglow enables complete environmental impact evaluation of product portfolios in weeks rather than months. The partnership covers Scope 1, 2, and 3 carbon footprint measurement, ingredient/packaging/process change modeling, and eco-design optimization. Deployed initially at Roval (2024 pilot), extended to Eurowipes, Chemineau, and Sicaf in 2025, with 4 additional sites planned for January 2026. Over 2,700 product references analyzed in 2025.
• CORADINminorStrategic or Co-development PartnerCollaboration between ANJAC's formulation expertise and CORADIN's packaging innovation, resulting in the Super Serum EXTEMPO product. Uses CORADIN's Simple Mixing Dropper ECODIS 2-in-1 packaging with ANJAC's extemporaneous formulation technology, where active ingredients are stored in a dedicated cartridge and activated at moment of use for optimal freshness and efficacy.
• DynvibeminorStrategic or Co-development PartnerANJAC collaborated with Dynvibe to analyze the evolution of pet care toward skin health, decoding consumer trends and biological needs of companion animals. The partnership supports ANJAC's development of dermo-petcare solutions leveraging human health science expertise.
• EcoBeautyScore ConsortiumminorStrategic or Co-development PartnerANJAC committed to joining the EcoBeautyScore consortium, an industry collective initiative to standardize environmental impact measurement for cosmetic products, reinforcing the group's sustainability actions and industry-wide impact on environment and climate.
• INRAE / AP-HP (Le French Gut)minorStrategic or Co-development PartnerPartnership with INRAE (Institut national de recherche pour l'agriculture, l'alimentation et l'environnement) and AP-HP (Assistance Publique - Hôpitaux de Paris) for the Le French Gut microbiota research project, contributing to ANJAC's health innovation strategy.

Scale indicators10 records

Recent moves6 records

Expansion highlights7 records

Emerging players

• CPL Aromas: Independent fragrance compounding house offering formulation and manufacturing services for personal care and home care brands. Comparable to ANJAC's fragrance and sensory formulation business units (Stephid, Roval Cosmétiques).
• Sederma (Croda Beauty): Croda's specialty ingredient business serving the personal care market with bioactive ingredients. Comparable to ANJAC's proprietary actives and formulation technology development (Biodis+, Cicalyte, Emulpro).

Direct peers

• Fareva: French family-owned CDMO providing formulation, manufacturing, and packaging for cosmetics, pharmaceuticals, and household products. Directly comparable to ANJAC as a privately held European beauty/health CDMO with a multi-subsidiary structure and similar customer profile.
• Albéa Group: Global leader in beauty packaging and full-service beauty solutions including formulation and tube/compact manufacturing. Closely comparable to ANJAC's beauty-focused subsidiaries (Aircos Pascual, Cosmetix West, Stephid) for color cosmetics and personal care turnkey solutions.

Broad incumbents

• Givaudan: Global leader in fragrances and beauty actives with significant CDMO and ingredient supply to beauty brands. Comparable to ANJAC's fragrance (Stephid) and sensory formulation capabilities across beauty and personal care.
• Recipharm: European CDMO providing development, manufacturing, and packaging services for pharmaceuticals across multiple dosage forms. Comparable to ANJAC's health-pharma business unit covering topical/oral pharma and OTC manufacturing.
• Eurofins CDMO: Large contract development and manufacturing services division of Eurofins Scientific, serving pharma and cosmetic clients. Comparable to ANJAC's analytical testing and formulation services across beauty and health products.
• Catalent (Novo Holdings): Global CDMO providing drug development, delivery technologies, and manufacturing solutions. Comparable to ANJAC's pharma CDMO capabilities, particularly in formulation innovation and complex drug delivery formats.
• Corden Pharma: Full-service CDMO offering APIs, drug products, and packaging across small molecules and biologics. Comparable to ANJAC's integrated pharma formulation and manufacturing services through Chemineau, Feltor, and Pillar5 Pharma.

Regional players

• Pierre Fabre Group: French pharmaceutical and dermo-cosmetic group with in-house manufacturing and contract services. Comparable to ANJAC's pharmaceutical manufacturing and dermocosmetics operations (e.g., Laboratoires Chemineau, Shadeline).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/anjac-heath-beauty/jobs

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ANJAC SAS